Brian Alan LANMAN
31Patents
11h-index
98Co-inventors
78Inventor score
Filing activity: Nov 5, 2001 → Mar 10, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10519146B2 | KRAS G12C inhibitors and methods of using the same | Chemistry; Metallurgy | 45 | Active |
| US10532042B2 | KRAS G12C inhibitors and methods of using the same | Emerging Cross-Sectional Technologies | 36 | Active |
| US10640504B2 | Inhibitors of KRAS G12C and methods of using the same | Human Necessities | 30 | Active |
| US11090304B2 | KRAS G12C inhibitors and methods of using the same | Chemistry; Metallurgy | 23 | Active |
| US10988485B2 | KRAS G12C inhibitors and methods of using the same | Chemistry; Metallurgy | 22 | Active |
| US9090593B2 | Bicyclic compounds as Pim inhibitors | Chemistry; Metallurgy | 22 | Active |
| US11053226B2 | KRAS G12C inhibitors and methods of using the same | Chemistry; Metallurgy | 21 | Active |
| US11096939B2 | KRAS G12C inhibitors and methods of using the same | Chemistry; Metallurgy | 19 | Active |
| US11045484B2 | KRAS G12C inhibitors and methods of using the same | Human Necessities | 19 | Active |
| US7919519B2 | S1P receptor modulating compounds and use thereof | Chemistry; Metallurgy | 13 | Active |
| US11285135B2 | KRAS G12C inhibitors and methods of using the same | Emerging Cross-Sectional Technologies | 13 | Active |
| US11285156B2 | Substituted piperazines as KRAS G12C inhibitors | Human Necessities | 11 | Active |
| US11306087B2 | Inhibitors of KRAS G12C and methods of using the same | Human Necessities | 11 | Active |
| US11905281B2 | KRAS G12C inhibitors and methods of using the same | Chemistry; Metallurgy | 8 | Active |
| US11766436B2 | KRAS G12C inhibitors and methods of using the same | Chemistry; Metallurgy | 5 | Active |
| US10632128B2 | Compounds that inhibit Mcl-1 protein | Chemistry; Metallurgy | 5 | Active |
| US8772480B2 | Inhibitors of PI3 kinase and/or mTOR | Chemistry; Metallurgy | 4 | Active |
| US12083121B2 | Substituted piperazines as KRAS G12C inhibitors | Human Necessities | 4 | Active |
| US11993597B2 | Inhibitors of KRAS G12C and methods of using the same | Human Necessities | 4 | Active |
| US8080542B2 | S1P receptor modulating compounds and use thereof | Chemistry; Metallurgy | 2 | Active |
| US7842685B2 | S1P1 receptor agonists and use thereof | Human Necessities | 1 | Active |
| US6809099B2 | Saframycins, analogues and uses thereof | Human Necessities | 1 | Expired |
| US11224601B1 | Compounds that inhibits MCL-1 protein | Chemistry; Metallurgy | 0 | Active |
| US11845760B2 | PRMT5 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10821115B2 | Compounds that inhibit Mcl-1 protein | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.